Supernu Chief Executive Officer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Supernus Pharmaceuticals, Inc (NASDAQ:SUPN) Q1 2024 Earnings Call Transcript

Supernus Pharmaceuticals, Inc (NASDAQ:SUPN) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Tim decPeter vozzoJack khattarSupernus pharmaceuticals incSupernus pharmaceuticals first quarterBiggest oil producing countries in asiaSupernus pharmaceuticalsCall transcript mayResults conferenceInvestor relationsSupernus pharmaceuticalSupernu chief executive officerChief financial officerRisk factorsCelebrities actually wearOil producing countries

Supernus Pharmaceuticals, Inc (NASDAQ:SUPN) Q3 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to Supernus Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. At this time all participants are in a listen-only mode.

Andrew tsaiDavid amsellemJack khattarTim decPiper sandlerPeter vozzoSupernus pharmaceuticalsSupernus pharmaceuticals third quarterSupernus pharmaceuticals incCall transcript novemberResults conferenceInvestor relationsSupernus pharmaceuticalSupernu chief executive officerChief financial officerRisk factors

Supernus Pharmaceuticals, Inc (NASDAQ:SUPN) Q1 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to Supernus Pharmaceuticals First Quarter 2023 Financial Results Conference Call. At this time all participants are in a listen-only mode.

Tim decJack khattarPeter vozzoDavid amsellemPiper sandlerAndrew tsaiSupernus pharmaceuticalsBiggest immunotherapy companiesHealth photoSupernus pharmaceuticals incSupernus pharmaceuticals first quarterCall transcript mayResults conferenceInvestor relationsSupernus pharmaceuticalSupernu chief executive officer

Supernus Pharmaceuticals, Inc (NASDAQ:SUPN) Q4 2022 Earnings Call Transcript

Operator: Good afternoon, and welcome to Supernus Pharmaceuticals Fourth Quarter and Full Year 2022 Financial Results Conference Call. At this time all participants are in a listen-only mode.

Jack khattarTim decDavid amsellemAndrew tsaiPiper sandlerPeter vozzoHealth photoSupernus pharmaceuticalsSupernus pharmaceuticals fourth quarterSupernus pharmaceuticals incCall transcript februaryFull yearResults conferenceInvestor relationsSupernus pharmaceuticalSupernu chief executive officer

Supernus Pharmaceuticals, Inc (NASDAQ:SUPN) Q3 2022 Earnings Call Transcript

Operator: Good afternoon and welcome to Supernus Pharmaceuticals Third Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Jack khattarTim decDavid amsellemPiper sandlerPeter vozzoMost overvalued companiesSupernus pharmaceuticalsSupernus pharmaceuticals incCall transcript novemberSupernus pharmaceutical third quarterResults conferenceInvestor relationsNathaniel yeoSupernus pharmaceuticalSupernu chief executive officerChief financial officer